Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 06, 2021 14:52 ET | Source: Parexel International LLC

Parexel จะถูกซื้อกิจการโดย EQT Private Equity และ Goldman Sachs Asset Management

บอสตันและเดอรัม, N.C., July 07, 2021 (GLOBE NEWSWIRE) -- Parexel องค์กรวิจัยทางการแพทย์ชั้นนำระดับโลก (CRO) ที่มุ่งเน้นการพัฒนาและส่งมอบการรักษาแบบใหม่เพื่อความก้าวหน้าด้านสุขภาพของผู้ป่วย...
July 06, 2021 14:52 ET | Source: Parexel International LLC

Parexel akan Diperoleh oleh EQT Private Equity dan Goldman Sachs Asset Management

BOSTON dan DURHAM, N.C., July 07, 2021 (GLOBE NEWSWIRE) -- Parexel, sebuah organisasi penyelidikan klinikal global (CRO) terkemuka yang berfokus pada pembangunan dan penyampaian terapi baharu yang...
July 02, 2021 10:33 ET | Source: Parexel International LLC

Parexel to be Acquired by EQT Private Equity and Goldman Sachs Asset Management

BOSTON and DURHAM, N.C., July 02, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
May 20, 2021 07:00 ET | Source: Parexel International LLC

Parexel Introduces Discussions on Diversity Research to Promote Diversity in Clinical Trials

BOSTON and DURHAM, N.C., May 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the release of “Discussions on Diversity,” an in-depth...
May 13, 2021 09:00 ET | Source: Parexel International LLC

Parexel Recognized as Most Favored Provider in ISR CRO Phase I Quality Benchmarking Report

BOSTON and DURHAM, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
May 04, 2021 09:00 ET | Source: Parexel International LLC

Parexel Achieves Top Rankings in Industry Across Multiple Attributes in ISR CRO Phase II-III Benchmarking Report

BOSTON and Durham, N.C., May 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
February 04, 2021 07:00 ET | Source: Parexel International LLC

Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials

BOSTON and DURHAM, N.C. and FT. MYERS, Fla., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve...
January 13, 2021 09:00 ET | Source: Parexel International LLC

Parexel and Signify Health Collaborating to Develop New Solutions to Promote Access and Inclusion in Clinical Trials

Companies partnering to reduce social determinants of health barriers to clinical trial enrollment BOSTON, DURHAM, N.C. and DALLAS, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Parexel and Signify Health...
January 11, 2021 06:00 ET | Source: Parexel International LLC

Parexel Completes Separation of Parexel Informatics and Medical Imaging Business

Strategic move enhances value and growth for both companiesParexel Informatics to relaunch as Calyx BOSTON and DURHAM, N.C., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of...
January 04, 2021 10:00 ET | Source: Parexel International LLC

Parexel Names Clare Grace to Newly-Created Role of Chief Patient Officer

BOSTON and DURHAM, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...